Brinsupri (Brensocatib)

Brinsupri (brensocatib) is a dipeptidyl peptidase 1 (DPP1) inhibitor used for the treatment of non-cystic fibrosis bronchiectasis in adult and pediatric patients aged 12 years and older.

Recommended Dosage:
The recommended dosage of Brensocatib is either 10 mg or 25 mg, taken orally once daily, with or without food. Patients should take the medicine at the same time each day for the best results. If a dose is missed, simply take the next dose at the regular scheduled time on the following day. To compensate for a missed dose, do not take two doses; this could increase the likelihood of adverse effects. Always do as your doctor directs.

• Skin-related side effects such as rashes, itching, or peeling may result from taking Brensocatib 10 mg/25 mg tablets. To detect any new or worsening skin conditions, patients should be closely monitored. Under medical supervision, treatment modification or cessation should be considered if severe dermatologic reactions occur.
• Gum and dental problems, such as gingival swelling, tenderness, or periodontal disease, may arise from Brensocatib treatment. Throughout therapy, routine dental examinations and proper oral hygiene are advised. Patients should notify medical personnel right away if they experience any gum bleeding, pain, or oral discomfort.
• Brensocatib may affect how well live attenuated vaccines work in the body. Generally speaking, these vaccinations should be avoided while undergoing treatment. Patients should speak with their healthcare providers about other vaccine options or carefully scheduled vaccinations to reduce risks if they are required.
• It is unknown if this drug is safe for pregnant women. Only if the possible advantages outweigh the risks to the unborn child should it be used during pregnancy. Before beginning therapy, pregnant patients should talk to their healthcare provider about treatment options and possible risks.
• Brensocatib’s ability to enter breast milk is unknown. It is not advised to breastfeed while taking this medication because it could endanger the nursing child. When deciding whether to stop breastfeeding or take Brensocatib, patients should speak with their healthcare provider.
• Brensocatib’s efficacy and safety in young patients have not been proven. Until sufficient research is available, use in children is not advised. Before treating any paediatric patient with Brensocatib, doctors should carefully weigh the risks against the potential benefits.

What documents are required to import BRINSUPRI to India?

BRINSUPRI (brensocatib) tablets can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is BRINSUPRI available in India?

BRINSUPRI (brensocatib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Brinsupri in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

BRINSUPRI can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of BRINSUPRI (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork-in-253190.hostingersite.com for Brinsupri tablets 10 mg/25 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source BRINSUPRI (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Brinsupri®?

Brensocatib is the Generic Name for the trade name drug Brinsupri®.

What is the Manufacturer’s Name of Brinsupri®?

Brinsupri® is manufactured by Insmed Incorporated.

Is Brinsupri approved by the FDA?

Yes. Brinsupri is approved by the FDA. Date of first approval: August 12, 2025.

What is the dosage and form of Brinsupri® supplied?

Brinsupri is supplied as Tablets: 10 mg and 25 mg for oral administration.

What are the most common side effects of Brinsupri® Tablets?

The most commonly reported side effects of Brinsupri® are upper respiratory tract infection, hyperkeratosis, headache, rash, dry skin, hypertension.

How much does Brinsupri® Tablet cost in India?

Brinsupri® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Brinsupri prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Brinsupri tablets 10 mg/25 mg cost in India, please call/WhatsApp +91-9310090915 or send an email to info@indianpharmanetwork-in-253190.hostingersite.com.

Can Brinsupri® 10 mg/25 mg tablets be available in SAARC countries?

Apart from Gulf countries, Brinsupri® can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Brinsupri® tablets in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Brinsupri® tablets online in India?

Yes, one can buy Brinsupri 10 mg/25 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the legal supply of Brinsupri® tablets through legal channels.

What are the storage conditions of Brinsupri® 10 mg/25 mg Tablets?

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F). Store these tablets in original container.